NLRP3i
NLRP3 inflammasome inhibitor / NLRP3 inflammasome inhibitor which likely acts via interfering with the formation of the NLRP3 inflammasome complex and which exhibits promising in vivo protective activities in mouse acute myocardial infarction models. It blocks ASC aggregation, blocks the release of IL-1 and the activation of caspase-1 in macrophages expressing constitutively active NLRP3 but does not directly inhibit caspase-1.1,2 Limits infarct size after myocardial ischemia-reperfusion as well as leukocyte infiltration in a peritonitis model in mice.2
Biochemicals & reagents
16673-34-0
JC121
1) Fulp et al. (2018), Structural Insights of Benzenesulfonamide Analogues as NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization; J. Med. Chem., 61 5412 2) Marchetti et al. (2014), A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse; J. Cardiovas. Pharmacol., 63 316
RT
TARGET: Inflammasome -- PATHWAY: Cytokine -- RESEARCH AREA: Immunology; Neuroscience -- DISEASE AREA: Heart disease; Neurodegeneration